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Murine Neonatal Melanocytes Exhibit a Heightened
Proliferative Response to Ultraviolet Radiation and
Migrate to the Epidermal Basal Layer
Graeme J. Walker1, Michael G. Kimlin2, Elke Hacker1, Sugandha Ravishankar1, H. Konrad Muller3,4,
Friedrich Beermann5 and Nicholas K. Hayward1
Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a
protective response. We have studied the melanocyte proliferative response after a single UVR exposure to
neonatal mice. At 3 days post-UVR in wild-type neonates we observed a marked melanocyte activation not seen
in adults. Melanocytes migrated to the epidermal basal layer, their numbers peaking at 3–5 days after UVR then
diminishing. They appeared to emanate from the hair follicle, migrating to the epidermis via the outer root
sheath. In melanoma-prone mice with melanocyte-specific overexpression of HrasG12V, basal layer melanocytes
were increased in size and dendricity compared to UVR-treated wild-type mice. Melanocytes in mice carrying a
pRb pathway cell-cycle defect (oncogenic Cdk4R24C) did not show an enhanced response to UVR such as those
carrying HrasG12V. The exquisite sensitivity to UVR-induced proliferation and migration that characterizes
neonatal mouse melanocytes may partly explain the utility of this form of exposure for inducing melanoma in
mice that carry oncogenic mutations.
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INTRODUCTION
Malignant melanoma (MM) development is strongly influenced
by sun exposure. But MMs often appear on non-sun-exposed
body sites (Whiteman et al., 2003, 2006), and office workers are
at higher risk than outdoor workers (Beral and Robinson, 1981;
Rivers, 2004). Individuals developing MMs at anatomical sites
associated with intermittent sun exposure (e.g., trunk) often also
carry many nevi (Whiteman et al., 2003), indicating that the
innate propensity of melanocytes (MCs) to proliferate may play
an underlying role in trunk lesions. UVR can induce an increase
in epidermal MC numbers in human (Quevedo et al., 1965;
Stierner et al., 1989; Scott and Haake, 1991), and mouse (Sato
and Kawada, 1972; Rosdahl and Szabo, 1978; Quevedo and
Fleischmann, 1980) skin, particularly after multiple exposures.
There may be interindividual variation in this MC proliferative
response (Stierner et al., 1989; Scott and Haake, 1991). MC
activation should be protective, in terms of inducing melanin
synthesis. However the propensity of an individual’s MCs to
proliferate in response to sun damage has been suggested as a
factor that may play a role in MM risk, at least in a subset of MM
cases (Grichnik et al., 1998; Silvers and Mintz, 1998; Rivers,
2004; Lin and Fisher, 2007).
Most mouse MM models carry mutations that upregulate
the Ras/Raf/MAPK and/or Akt/PI3K pathways in MCs
(Tyr-HrasG12V, Tyr-NrasQ61K), or in both keratinocytes and
MCs (Mt-Hgf/Sf, Grm1; Mt-Ret) (reviewed in Walker and
Hayward, 2002). Such genetic modifications can induce
melanocytosis and MM, with UVR exposure generally
increasing penetrance and reducing age of onset. Penetrance
is increased if transgenics are crossed with mice carrying p53
(Bardeesy et al., 2001; Kannan et al., 2003) or pRb (Recio
et al., 2002; Kannan et al., 2003; Ackermann et al., 2005;
Hacker et al., 2006) pathway defects.
In Hgf/Sf transgenic mice a single neonatal UVR exposure
effectively induces MM, whereas adult doses do not (Noonan
et al., 2001). This process appears to be driven by UVB, as
neonatal UVA was ineffective at inducing MM (De Fabo
et al., 2004). The action spectrum for non-MM skin carcino-
genesis in mice peaks at 293 nm (de Gruijl et al., 1993),
squarely within the UVB band. However UVA1 (340–400 nm)
has also been suggested to be important in MM development.
Whereas UVB is absorbed strongly by DNA, UVA is
absorbed only weakly, and may induce damage indirectly
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by photosensitizing other molecules by which it is absorbed,
resulting in free radical formation. A single UVA dose does
not induce MC proliferation in adult mice, which UVB does
effectively (van Schanke et al., 2005).
The reason for the sensitivity of murine neonatal, but
not adult MCs, to UVR-induced transformation is unclear
(Wolnicka-Glubisz and Noonan, 2006). As neonatal mice have
a defective inflammatory response to UVR (Wolnicka-Glubisz
et al., 2007), it may involve the relative immaturity of the
immune system. An alternative hypothesis involves the location
of MCs in the skin. In adult mice, MCs are restricted to hair
bulbs (except in certain anatomical locations such as the tail
and ears), rather than the epidermis as in humans. In neonates,
MCs are transiently within the epidermis, but migrate into hair
bulbs before postnatal day 10 (Hirobe, 1984). Thus UVR
treatment of neonates probably results in damaged epidermal
MCs, whereas in adult mice this would not be the case.
We have shown that mice carrying MC-specific activation of
HrasG12V (Tpras) are highly MM prone after a single neonatal
but not chronic adult UVR exposure (Broome Powell et al.,
1999; Hacker et al., 2005). MMs were small and in situ. When
these mice were also homozygous for the Cdk4 mutation
(R24C) that makes the kinase insensitive to p16Ink4a inhibition
(Rane et al., 1999), neonatal UVR decreased age of onset and
increased tumor aggressiveness (Hacker et al., 2006). As UVR
is known to activate MCs in vivo, we hypothesized that this
response may be exacerbated in neonatal mice. We examined
UVR-induced MC proliferation in Tpras (Broome Powell et al.,
1999), Tyr-NrasQ61K (Tyr-Nras) (Ackermann et al., 2005) and/or
oncogenic Cdk4 (Rane et al., 1999) mice, to determine whether
it may be a factor in neonatal UVR-induced melanomagenesis,
and whether UVR exposure has a similar effect on MCs
carrying activation of NRAS, given that NRAS mutations are
more common than HRAS mutations in human MM. We
collected skin from UVR-treated mice and used immunofluor-
escence to detect MCs staining for Trp1 (a MC marker) and/or
Trp2 (a marker for both MCs and melanoblasts); and Ki-67,
which stains cycling cells (Gerdes et al., 1984). We chose to
study dorsal skin as this is where the great majority of UVR-
induced MMs develop in the murine models we have studied
(Hacker et al., 2006).
RESULTS
Melanocyte activation in wild-type mice
We often noted retarded hair growth in pups for a few days
after neonatal UVR treatment (Figure 1a), after which the hair
grows normally. At 24 hours post-UVR, we tended to observe
few Ki-67-positive proliferating cells and isolated areas of
seemingly disorganized epidermis in exposed skin (Figure
1b). This contrasted with the well-demarcated epidermis,
with proliferating basal cells, in shielded skin (Figure 1b, right
panels). Notably, at 24 hours after UVR no Trp1 or Trp2-
staining MCs were visible in the damaged epidermis, they
were only located within hair bulbs (not shown). Surprisingly,
at day 3 post-UVR, we observed MCs in the epidermal basal
layer (Figure 1c) in the UVR exposed but not the shielded side
of the animal. Importantly, in adult wild-type (wt) dorsal skin
after a single exposure of equal intensity, MCs did not appear
at the basal layer (Figures 1d and 2a). In the neonates, the
attraction of MCs to the basal layer in neonates (not observed
at 24 hours postneonatal UVR) seemed to correlate with
increased basal keratinocyte proliferation, observed at 5 days
post-UVR in exposed and not shielded skin (Figure 1c).
Comparison of MC number in the epidermis at various time
points (including those preexisting at postnatal day 3, P3, at
the time of neonatal UVR) indicates that epidermal basal MC
density is extremely low at 1 day after UVR, peaks at 3–5
days, along with increasing basal keratinocyte proliferation,
then gradually diminishes (Figure 2b), presumably after the
damaged epidermis is renewed.
Melanocyte activation in Ras transgenics
Table 1 details the spontaneous and UVR-induced melanoma
susceptibility of the mouse strains used in this study.
MCs migrating to the basal layer in MM-prone Tpras and
Tyr-NrasQ61K mice tended to be larger and more dendritic (for
example, Figure 1e) than those in wt UVR-treated skin.
Dendritic processes were often multipolar, compared to the
generally bipolar wt basal MCs. The Ras-expressing MCs
appeared anchored on the basal membrane, with dendrites
reaching up toward the suprabasal epidermis (Figure 1e and f),
as is normally seen in human skin. In isolated pockets,
MCs appeared to line nearly the whole of the basal layer
(Figure 1f), although the density of infiltration varied along a
particular skin section. This phenomenon was not seen in
UVR-treated wt skin, where basal MCs were separated, and
not in chains as in Figure 1f. Extra-follicular dermal MCs in the
shielded dorsal skin of Tpras (Figure 1f) and Tyr-Nras mice
(Ackermann et al., 2005) are part of the phenotype of these
transgenics due to constitutive Ras activation. These cells lie
close to, but beneath, the dermal–epidermal junction, with
dendrites following the curve of the basal layer. Only in UVR-
exposed skin do MCs become resident in the basal layer.
Despite qualitative differences in the size and dendricity
between the wt and Ras-expressing basal MCs, this was not
always accompanied by significant differences in cell
number. When basal MC density was assessed, (Figure 2c),
there was a trend for greater numbers (than wt) in genotypes
carrying a Ras transgene, only reaching statistical significance
for Tyr-Nras at 3 days post-UVR. We observed no difference
in UVR-induced basal MC numbers between mice carrying
combined Cdk4 and Ras mutations from those carrying Ras
only (Figure 2c), or between wt and Cdk4R24C/R24C mice (not
shown). In all genotypes, basal MC density was decreased by
2 weeks post-UVR (Figure 2d). Unlike adult wt mice, where
we observed no basal MCs post-UVR, an equivalent dose to
8-week-old Tpras mice resulted in the appearance of small
numbers of basal MCs (Figures 1g and 2a). However basal
MC density after UVR was significantly lower in adult Tpras
skin than in neonatal Tpras skin (Figure 2a), and the adult
basal MCs were generally smaller.
UVR-induced melanocyte proliferation in melanoma-prone
mice
We sought to determine the proportion of UVR-activated
basal MCs that stained for both Trp1 and Ki-67 (Figure 3a).
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At least 24% (up to 40% in Cdk4R24C/R24C/Tpras mice) of
these cells were proliferating. Thus, in the epidermis MCs are
highly activated and appear capable of subsequent expan-
sion. This further underlines a predictable, but pivotal
difference between MCs in neonatal versus adult mice, their
propensity for proliferation and activation post-UVR. We also
assessed the dermal population of MCs in the Tpras and
Cdk4R24C/R24C/Tpras animals. In total, 36–40% (Figure 3b) of
these dermal MCs stained for Ki-67, indicative of the hyper-
proliferative phenotype induced by MC-specific expression of
HrasG12V. However, we saw no difference in the proportion
of these cells proliferating after neonatal UVR. Thus untreated
Ras-expressing dermal MCs are also characterized by high
levels of proliferation that was not measurably increased by
neonatal UVR. In terms of MC localization within the skin,
their appearance in the basal layer is the most prominent
response to neonatal UVR in both wt and MM-prone
transgenic mice.
Tpras adult + UVRTpras adult +UVR
Cdk4/Tpras –UVRCdk4/Tpras +UVR
Tpras –UVRTpras +UVR
wt adult –UVRwt adult +UVR
wt –UVR
wt –UVRwt +UVR
wt +UVR
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Figure 1. UVR-induced melanocyte proliferation. (a) Inhibition of hair growth 3 days postneonatal UVR (P6). At UVR exposure, the left side of the animal was
shielded with UVR-blocking tape. (b) UVR-exposed wt dorsal skin 24 hours post-exposure (P4), showing low levels of proliferating basal keratinocytes,
giving the appearance of a disorganized epidermis. Sections were stained for proliferating cells (Ki-67, green) and nuclei (DAPI, blue). Right panel shows shielded
skin of the same mouse, with proliferating keratinocytes (green) along a sharply defined basal layer; (c) 5 days post-UVR (P8). Trp1-staining (red) dendritic MCs
can be seen residing in the basal layer in UVR-exposed, and not the shielded side (right panels). Ki-67 staining along the basal layer is greatly increased and
epidermis thickened. Neither can be observed in shielded skin, with MCs strictly limited to hair follicles. (d) Shaved UVR-treated skin (4 days after UVR) from an
8-week-old wt mouse. Right panels show nonshaved (shielded) skin from the same animal. Dermal fluorescence in UVR-treated skin is due to background
fluorescence of red blood cells. (e) UVR-exposed (left) and shielded (right) Tpras skin, showing dendritic MCs in the basal layer at 5 days post-UVR (P8).
Dendrites extend up into the epidermis, as in human skin. Note dermal MCs in both UVR-treated and shielded Tpras skin. (f) UVR-exposed (left) and shielded
(right) skin of Cdk4R24C/R24C/Tpras mouse at 5 days post-UVR (P8). Isolated aggregations of MCs can be observed along the basal layer after neonatal UVR, but
not in shielded skin. (g) Shaved and UVR-treated skin (4 days after UVR) from an 8-week-old Tpras mouse. Arrow indicates an epidermal basal layer MC. The
right panels show nonshaved (shielded) skin from the same animal. Green staining in the dermis is nonspecific background fluorescence. Scale bar¼ 100mM.
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DNA repair of damaged melanocytes in Tpras and
Cdk4R24C/R24C/Tpras mice
To determine whether UVR-induced MC proliferation in the
transgenic mice may inhibit DNA repair, we assessed
removal of cyclobutane pyrimidine dimers (CPDs) after
neonatal UVR. If Tpas or Cdk4R24C/R24C/Tpras MCs were
defective in DNA damage repair, we would expect to see
repair substantially completed after 3–4 days in keratinocytes
(Tron et al., 1998; Figure S1a), but not in MCs. By double-
label immunofluorescence staining we detected CPDs in the
epidermis and upper dermis (Figure 3c). Overlay of Trp1 and
CPD staining revealed many damaged MC nuclei after
neonatal UVR (Figure 3d). Although damaged MCs and
keratinocytes could be observed at 48 hours post-UVR, CPDs
were cleared in both cell types by 5 days (Figure 3d). Thus,
we found no evidence that CPDs were repaired more slowly
in MCs than keratinocytes. Notably, neither UVR-activated
basal layer MCs, or those in the dermis, showed evidence of
retaining CPDs. We cannot rule out the possibility that MCs
may not have repaired some DNA lesions, but there is no
indication of a significant repair defect in these hyperproli-
ferating mutant MCs in vivo. Removal of CPDs appears to be
substantially completed by the time of maximum MC
migration to the epidermal basal layer.
Effect of UVA on melanocyte proliferation in neonatal mice
On basis of the data of De Fabo et al. (2004), we predicted
that if epidermal MC proliferation/activation is important for
MM induction, one would not expect UVA to increase
epidermal MC numbers. We exposed wt mice to a single
neonatal UVA dose of 81 kJm2. In contrast to UVB-treated
littermates, we did not observe any MCs in the epidermal
basal layer at 3 or 6 days post-UVR (Figure 4). In the UVA-
treated skin, we did not observe increased Ki-67-staining
basal cells, or epidermal thickening. Thus in neonatal mice
UVR-induced MC proliferation is largely driven by UVB
photoproduct formation.
Origin of UVR-activated basal melanocytes in mice
Insertion into the epidermal basal layer of preexisting
epidermal MCs. As MCs are present in the epidermis in
neonates, and not in adult mice, we hypothesized that these
cells may amplify and insert into the basal layer after neonatal
UVR. We stained skin from untreated wt mice at P1-P10 for
Trp1 and Trp2. From P1–10, epidermal MCs (mainly
suprabasal, Figure 5a) peak, then diminish in number (Figure
5b) as they migrate downward into the developing hair
follicle via the outer root sheath (ORS). They are undetectable
in the epidermis by P10 (in accord with Hirobe, 1984). At P3,
the time of neonatal UVR, the density of these suprabasal
MCs varied between genotypes (Figure 5c), with the Tpras
animals having surprisingly few, but Tyr-Nras mice having a
relatively high density. Both Ras genotypes exhibited
comparable basal MC numbers post-UVR. The fold increase
for different genotypes was wt (5.6), Tpras (36.8), and Nras
(3.8). Thus the numbers of preexisting suprabasal epidermal
MCs does not correlate well with the subsequent basal MC
counts post-UVR. The density of preexisting extra-follicular
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Figure 2. UVR-induced basal melanocyte number in different strains.
Mean basal MC number (±SEM) per  40 field over the length of each
section (over B20–25 fields per section) is plotted against days postneonatal
UVR. (a) Comparison of basal MC count after neonatal UVR in neonates
and adults (wt and Tpras, respectively), n¼4 for each time point.
*Mann–Whitney U-test Po0.05. (b) Epidermal MC density for wt mice
plotted at P3 (preexisting MCs) and from days1–14 after neonatal UVR.
(c) wt mice compared to Tpras and Tyr-Nras transgenics and/or compound
genotypes with Cdk4R24C. Sections were analyzed from at least 3 different
mice (except for Cdk4R24C/R24C/Tpras at 5 days, n¼ 2), from at least 2 different
litters). *Mann–Whitney U-test Po0.05. (d) Basal MC count at 5 and 14 days
post-UVR (nX30. Some MCs remain in the basal layer for up to 2 weeks
postneonatal UVR. Mean counts for wt and Tpras are significantly lower at
14 days than at 5 days post-UVR (*Mann–Whitney U-test Po0.05). For
Tyr-Nras P¼ 0.077.
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dermal MCs also varies between genotypes (Hacker et al.,
2005; Figure S1b; shown schematically in Figure 5e). Thus,
we cannot infer from differences in preexisting MC density
whether preexisting epidermal and/or interfollicular dermal
MCs may expand and insert into the basal layer after UVR.
The relative role of each MC population may depend on the
genotype-determined proliferative response of MCs to UVR,
or alternatively, all MC populations may be attracted to the
epidermal basal layer after UVR. Despite the different
preexisting MC populations, all genotypes have in common
the appearance of MCs in the basal layer after neonatal UVR.
Migration from hair follicles. An alternative scenario, based
on our observations, is a migratory model, with MCs
Table 1. Melanoma susceptibility of single and compound transgenic strains
MM penetrance at 1 year Average age-of-onset
Strain Spontaneous UVR induced Spontaneous UVR induced
Tpras 0%1 57%1 —1 35 weeks1
Tyr-NrasQ61K 15%2 ND 50 weeks2 ND
Cdk4R24/R24C/Tpras 58%3 83%3 36 weeks3 23 weeks3
Cdk4R24/R24C/Tyr-NrasQ61K ND ND ND ND
Abbreviations: MM, malignant melanoma; ND, not done.
We did not include wt mice as they do not develop MM after neonatal or repeated adult UVR. 1Hacker et al., 2005.
2Ackermann et al., 2005.3Hacker et al., 2006.
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Figure 3. Proliferation and DNA repair capability of MCs post-UVR. (a) Top panel shows overlay of Trp1 and Ki-67 staining (indicated by an arrow). Lower
panel shows Trp1-staining basal layer MCs post-UVR. Table shows the proportion of these UVR-activated basal MCs proliferating. (b) The proportion of
dermal MCs (indicated by an arrow) proliferating in UVR-treated and shielded Tpras and Cdk4R24C/R24C/Tpras skin. (c) Anti-CPD monoclonal antibody detects
dimers in UVR-exposed skin (left panel) but not shielded skin from the same animal (right panel). Mouse strain, Cdk4R24C/R24C/Tpras. Trp1 stain not included.
(d) Overlay of Trp1 (red) and CPD (green) staining post-UVR. Mouse strain-Cdk4R24C/R24C/Tpras in all panels. White arrows show DNA-damaged MC nuclei at
1 hour post-UVR, with decreased intensity at 2 days post-UVR. After 5, 6, and 8 days post-UVR (right panels), no CPDs can be detected in either MCs or adjacent
keratinocytes. Dermo-epidermal junction is marked by a dotted white line. The 5 days time point shows CPD-negative basal MCs (arrows with
dotted stems). The 7 and 8 days time points show CPD-negative dermal MCs. Scale bar¼ 100mM.
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emanating from the hair follicle. At the time of maximum
basal MC numbers, we observed Trp1/2-staining dendritic
MCs within the ORS in UVR-exposed wt skin (Figure 5f and h),
but not in shielded skin from the same animal (Figure 5g and i).
Here we concentrated on wt mice only, because in the Ras
models we cannot rule out direct insertion of extra-follicular
MCs into the ORS (at P3 wt mice have few, if any extra-
follicular dermal MCs, Figure S1b). With hair growth retarded
for a few days postneonatal UVR (Figure 1a), we observed
follicles in various stages of maturation at 3–5 days post-UVR.
In immature follicles, we saw MCs located along the
descending hair follicle epithelium post-UVR. However, in
well-developed follicles, by 5–6 days post-UVR MCs were
nearly always seen in the follicular infundibulum and in the
adjacent interfollicular epidermal basal layer (see Figure 5j
and k), and only very rarely below the bulge region. This is
consistent with a vertical (upward) migration of MCs toward
the epidermis via the ORS. Although both the Tpras and Tyr-
Nrasmice harbor preexisting dermal MC populations, in both
models MCs also appear in the ORS after UVR exposure
(Figure S1c).
DISCUSSION
Neonatal UVR exposure has become de rigueur for inducing
MMs in mice. We have examined mouse dorsal skin after
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neonatal UVR exposure and observed a remarkable propen-
sity for neonatal MCs to migrate to the basal layer of the
epidermis. For wt mice this migration was specific to the
neonatal period, as it did not occur in adult wt mice treated
with an equivalent single UVR dose, in accordance with the
conclusions of others (Jimbow and Uesugi, 1982; Noonan
et al., 2000; van Schanke et al., 2005). In addition, based on
Ki-67 positivity, a much higher proportion of MCs are
actively cycling in UVR-treated neonatal skin (from 24 to
40%; Figure 3a) compared to those in wt adult skin after a
single exposure (less than 1%; van Schanke et al., 2005).
Thus UVR-activated neonatal basal layer MCs are highly
proliferative and capable of further expansion, and develop-
mental age is pivotal in determining their propensity to
proliferate and migrate after UVR. This has also been reported
in wound-healing experiments with mice (Hirobe, 1988).
After neonatal wounding, MCs migrate to the healing
epidermis, their numbers reach a maximum at 3 days
postwounding, then decrease, reminiscent of our observa-
tions following neonatal UVR exposure. MC proliferation was
maximal with wounding at P1.5, at later ages the effect
decreased and it did not occur in 60-day-old mice (Hirobe,
1988).
MC activation after neonatal UVR was exacerbated in
mice carrying MC-specific oncogenic HrasG12V or NrasQ61K
mutations. The mutant MCs were increased in number in the
basal layer over wt levels and were often multidendritic,
whereas those in wt mice tended to be bipolar. The dorsal
epidermis in the MM-prone animals at 3–5 days postneonatal
UVR (Figure 1f) looks remarkably similar to human epider-
mis, with dendritic MCs sitting on the basement membrane
and dendrites extending up into the epidermis. The hyper-
activation of mutant MCs in the MM-prone mice after
neonatal UVR led us to ponder whether this MC response
is purely protective, or whether it may be involved in MM
initiation. One simple test was to expose neonatal mice to
UVA, which does not initiate MM in the albinoMt-Hgfmodel
(De Fabo et al., 2004). We observed no MC proliferation after
UVA exposure, indicating that the same type of UVR-induced
damage that induces MC migration also induces MM. This is
consistent with the data of van Schanke et al. (2005), where
UVA did not increase MC proliferation in adult mice, even
after a single dose of up to 1300 kJm2. We also tested the
capacity of the mutant MCs to repair UVB-induced DNA
damage. We found no evidence that they could not repair
pyrimidine dimers as well as adjacent cells in their
microenvironment, although we cannot rule out a role for
other types of DNA damage, including oxidative damage,
inhibition of which can delay age of MM onset in some
models (Cotter et al., 2007). We hypothesize that the
presence of highly activated MCs in an environment of
defective inflammatory response to UVR in neonates
(Wolnicka-Glubisz et al., 2007) may at least partially explain
the utility of this form of radiation exposure in inducing MM
in genetically modified mice. Our results support this
hypothesis, but further experiments will be needed to confirm
this possibility. Part of the excessive MC activation in our
MM-prone models could result from increased Ras transgene
expression due to UVR-induced factors binding to the
exogenous tyrosinase gene promoter. This does not alter the
proposition that neonatal UVR may be pivotal in placing
some MCs into a hyperactive state, although they need
concomitant Ras activation for transformation.
We previously showed that HrasG12V alone is sufficient, in
cooperation with neonatal UVR, to induce MM, whereas the
combination of Cdk4R24C/R24C and HrasG12V increases
penetrance, with the lesions being larger and more aggressive
(Hacker et al., 2006). Surprisingly, the presence of an
activating Cdk4 (R24C) mutation did not enhance UVR-
induced MC migration. This indicates that HrasG12V appears
to be driving MC proliferation and the initiation of MM after
neonatal UVR, whereas the Cdk4 mutation either exacerbates
the initiation process, or comes into play once an MC has
overcome a transformation threshold.
In addition to the appearance of MCs in the epidermal
basal layer, the most striking feature of UVR-treated skin in wt
neonatal mice is the appearance of dendritic MCs in the ORS
(Figure 5f, h and j). Treatment with chronic UVR or DNA
damaging agents can also stimulate MCs to invade the
epidermis via the ORS in adult mouse (Quevedo and
McTague, 1963; Sharov et al., 2003) and human (Staricco
and Miller-Milinska, 1962) skin. Our observations before and
after UVR in wt neonates suggest that just as neonatal MCs
normally migrate downward into the developing hair follicle
(Figure 5d, Peters et al., 2002), after UVR exposure they
appear to migrate upward, via the ORS, and by 6 days after
neonatal UVR they are mostly seen in the infundibula region
and the epidermal basal layer (Figure 5f–k). This is consistent
with activation and subsequent expansion of bulge MC stem
cells by UVR. These stem cells can resupply both the hair
bulb and epidermis with MCs when appropriately stimulated
(Nishimura et al., 2002). The presence of other MC
precursors, not expressing pigmentation-related antigens,
has been proposed in murine (Jimbow and Uesugi, 1982;
Kawaguchi et al., 2001) and human epidermis (Grichnik
et al., 1996; Horikawa et al., 1996). Although activation of
such MCs by UVR cannot be ruled out, epidermal grafting
experiments in animals and humans indicate that MCs can
migrate vertically, via the ORS, and horizontally, through the
interfollicular epidermis (Billingham and Silvers, 1970;
Horikawa et al., 1999; Nishimura et al., 2002; Yonetani
et al., 2008). This ‘‘pigment-spreading’’ phenomenon is
explained only by MC migration, not by activation of
preexisting MCs. Whether the UVR-activated epidermal basal
MCs in our study originate from activation, expansion, and
migration of an ORS MC population, or insertion into the
basal layer of another MC population(s), remains to be
determined.
Why might neonatal MCs be so sensitive to UVR-induced
proliferation and transformation? Normally, MC stem cells
are activated cyclically, at anagen, to resupply the follicle.
However, in neonatal mice the first hair bulbs are not
supplied by MC stem cells, but by MCs that are migrating
from the epidermis, in an environment of hair growth
stimulus, downward into the bulb (Peters et al., 2002; Mak
et al., 2006). Thus at P3, the time of neonatal UVR exposure,
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MCs are essentially in a unique developmental window when
their fate is being determined—they will migrate either into
the bulge niche (Nishimura et al., 2002), or the hair bulb
(Peters et al., 2002). Whether these MCs simply reverse their
trajectory, under a ‘‘wound’’ stimulus (from UVR), or whether
MC stem cells expand after UVR exposure is a fascinating
question, and we are performing further experiments to try to
elucidate the answer.
It is well known after epidermal MC density in the basal
layer can increase after UVR exposure, a response conserved
even in hairy-skinned animals that do not have a great need
for tanning. In neonatal mice, the appearance of basal MCs
coincides with proliferating basal keratinocytes (Figure 1c
and e), in a response likely to be driven by keratinocyte-
derived factors (Hirobe, 2004; Lin and Fisher, 2007). How-
ever, keratinocyte proliferation alone cannot explain the
attraction of MCs to the basal layer, as UVR-treated adult wt
mice show significant epidermal hyperproliferation after
UVR, but no MCs migrate to the basal layer (Figure 1d). It
will be interesting to determine which keratinocyte-to-MC
signaling pathway(s) is important for inducing MC migration
after neonatal UVR, and which innate characteristics of
neonatal MCs make them particularly sensitive to these
signals. MC activation in humans after sun exposure is a
protective response, helping to increase melanin production,
enhancing DNA repair, and inhibiting apoptosis of MCs
(reviewed in Abdel-Malek et al., 2008). Whether genetic
variation in humans that augment the response of an
individual’s MCs to UVR could increase susceptibility to a
particular pathway of MM development (as suggested by
Whiteman et al., 2003, and Rivers, 2004) remains to be
determined.
MATERIALS AND METHODS
Mouse melanoma models
Mouse models and genotyping have been previously described:
Cdk4R24C (Rane et al., 1999), Tyr-HrasG12V (Broome Powell et al.,
1999), and Tyr-NrasQ61K (Ackermann et al., 2005). Mice were bred
for at least three generations onto a friend virus B-type background.
Wild-type mice were littermate controls not carrying a Cdk4 or
oncogene Ras mutation. Experiments were undertaken with institute
animal ethics approval A98004M.
UVR treatments
Pups (3-day-old) were given a 20minutes exposure to UVB from a
bank of six cellulose acetate-filtered Phillips TL100W 12RS UVB
lamps (Total UVB dose, 5.9 kJm2, or an erythemally weighted
dose of 1.8 kJm2). UVB dose was measured using a Solar Light
(Glenside, PA) PMA2100 radiometer with either a PMA2101
detector to measure biologically weighted UVB or a PMA2106
detector to measure non-weighted UVB. The reason for the use of
this dose of UVB is historical. Comparable doses of UVB effectively
inducing MM in genetically modified mice (for example, Noonan
et al., 2001), probably in a dose-dependent manner (De Fabo et al.,
2004). Each pup was placed into a well of a six-well tissue culture
plate for the treatment, to prevent them huddling and screening each
other from the UVR. Animals were killed at 4 days post-UVR and a
portion of exposed skin excised. One side of selected litters was
shielded with black tape to generate untreated skin for the same
mouse. Three Mylar-filtered Phillips TLK40W/05 UVA lamps were
used for UVA exposures. The peak output is at 365 nm, a mercury
line (see Figure S1d for spectral output). Mice were exposed to
81.3 kJm2 of UVA, with pups placed 6.5 cm from the lamps for
50minutes. For adult exposures, a portion of dorsal skin was shaved
before the exposure of 8-week-old mice to the same UVB dose.
Controls were shaved mice not exposed to UVR, and nonshaved
(shielded) skin from the UVR-treated animal.
Dual-label immunofluorescence
Pups were killed with CO2 and a section of dorsal skin was
excised. Sections (3–4m) were dewaxed and antigen retrieval was
performed using the Dako pH-6 system (Dako, Eli, UK) at 125 1C
for 5minutes. Sections were blocked with 1% BSA and incubated
with rat monoclonal anti-Ki-67 (Dako) at 5 1C overnight. After
washing, biotinylated donkey anti-rat (Jackson ImmunoResearch
Laboratories, West Grove, PA) antibody was applied (at 1:300
dilution) for 1 hour, followed by washing, and incubation with FITC-
labeled streptavidin (1:300) for 1 hour. The second primary antibody
(anti-Trp1) was applied (1:300) for 1 hour. Rhodamine-labeled
donkey anti-rabbit (Jackson ImmunoResearch Laboratories) was
added (1:300) for 1 hour. Slides were mounted with Vector Shield
(Vector laboratories. Burlingame, CA) containing DAPI. Slides were
viewed on a fluorescent microscope and positive cells counted.
Basal MCs were quantitated by counting rhodamine-labeled (red)
dendritic cells overlaying the FITC-labeled (green) Ki-67-staining
nuclei in the epidermal basal keratinocytes. The number of basal
MCs per  40 field was counted, along the length of the skin
(normally from 15 and 25 fields per skin). MCs co-staining with
Ki-67 and Trp1 were counted (at  100 magnification) if the
DAPI-staining MC nucleus was clearly discernable from the
surrounding keratinocyte nuclei.
Double-staining for Trp2 and Trp1 was similarly performed,
except that after biotinylated donkey anti-rabbit (Jackson Immuno-
Research Laboratories) and Streptavidin-FITC (Jackson Immuno-
Research Laboratories) antibodies were added in the first labeling
(Trp2), slides were then blocked with rabbit FAB fragment before
the second primary antibody (Trp1) was applied. As a control for
crossreaction, the second rabbit primary antibody (Trp2) was left off
before the secondary antibody (rhodamine anti-rabbit) was applied.
We observed no red MCs that would have indicated crossreactivity
between the first primary antibody and final rhodamine-labeled
secondary antibody.
DNA repair
Sections were antigen retrieved, and DNA denatured in situ by
immersion of slides in the following solutions: 50% ethanol for
5minutes; 30% ethanol/0.02N HCl for 2minutes; 0.05N HCl for
5minutes; 0.07N NaOH/70% ethanol for 7minutes. Sections were
blocked for 1 hour with goat-anti-mouse FAB fragment, and then with
1% BSA. The first primary antibody (a-H3 monoclonal, Sigma,
Australia) was applied (1:100) overnight at 5 1C. Sections were
washed, and biotinylated donkey anti-mouse (Jackson Immuno-
Research Laboratories) was applied (1:300) for 1 hour, followed by
FITC-labeled Streptavidin (Jackson ImmunoResearch Laboratories;
1:300) for 1 hour. The subsequent dual-labeling step for Trp1 is
described above.
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Statistics
Statistical significance was determined for the difference in MC
numbers between genotypes using the Mann–Whitney U-test.
Calculations were performed using the SPSS computer program.
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